Your browser is no longer supported. Please, upgrade your browser.
HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsElite Help
publish chart | save to portfolio | create alert Type: candle | line | advanced | interactive | perf    Timeframe: intraday | daily | weekly | monthly
VIVO Meridian Bioscience, Inc. daily Stock Chart
VIVO [NASD]
Meridian Bioscience, Inc.
Healthcare | Diagnostic Substances | USA
statements
Index- P/E17.39 EPS (ttm)0.45 Insider Own0.90% Shs Outstand43.77M Perf Week-4.09%
Market Cap338.78M Forward P/E20.64 EPS next Y0.38 Insider Trans8.24% Shs Float42.38M Perf Month-20.86%
Income19.10M PEG1.02 EPS next Q0.08 Inst Own89.90% Short Float3.44% Perf Quarter-11.54%
Sales197.00M P/S1.72 EPS this Y10.10% Inst Trans-3.55% Short Ratio2.89 Perf Half Y-21.18%
Book/sh4.61 P/B1.68 EPS next Y20.97% ROA6.20% Target Price9.00 Perf Year-55.16%
Cash/sh1.57 P/C4.94 EPS next 5Y17.00% ROE10.10% 52W Range7.62 - 17.71 Perf YTD-20.78%
Dividend- P/FCF14.54 EPS past 5Y-7.30% ROI9.60% 52W High-56.30% Beta0.21
Dividend %- Quick Ratio3.10 Sales past 5Y1.30% Gross Margin58.00% 52W Low1.57% ATR0.57
Employees660 Current Ratio4.40 Sales Q/Q-8.00% Oper. Margin13.90% RSI (14)35.35 Volatility4.96% 7.78%
OptionableYes Debt/Eq0.00 EPS Q/Q-65.20% Profit Margin9.70% Rel Volume0.95 Prev Close7.91
ShortableYes LT Debt/Eq0.38 EarningsFeb 07 BMO Payout27.90% Avg Volume505.42K Price7.74
Recom3.00 SMA20-12.87% SMA50-17.71% SMA200-23.52% Volume479,184 Change-2.15%
May-01-19Upgrade Piper Jaffray Underweight → Neutral $15 → $11
Apr-03-19Downgrade Canaccord Genuity Hold → Sell $17 → $11
Jan-26-18Reiterated Canaccord Genuity Hold $14 → $16
Mar-28-17Initiated CL King Neutral
Mar-28-16Reiterated Canaccord Genuity Hold $18 → $19
Sep-10-15Reiterated Canaccord Genuity Hold $19 → $18
Jul-27-15Reiterated Canaccord Genuity Hold $20 → $19
May-04-15Reiterated Canaccord Genuity Hold $19 → $20
Nov-06-14Downgrade Robert W. Baird Outperform → Neutral $22 → $22
Jul-27-12Downgrade Canaccord Genuity Buy → Hold
Apr-25-11Upgrade Wedbush Underperform → Neutral $18 → $22
Mar-24-11Upgrade Canaccord Genuity Hold → Buy $30
Nov-16-10Initiated Canaccord Genuity Hold $21
Apr-07-10Initiated Wedbush Underperform $18
Nov-13-09Reiterated Caris & Company Average $21 → $20
Jul-07-09Initiated Caris & Company Average $21
Mar-06-09Initiated William Blair Mkt Perform
Oct-14-08Initiated Lazard Capital Buy $30
Jul-21-08Upgrade Hilliard Lyons Neutral → Long-term Buy
May-14-08Initiated Susquehanna Financial Neutral
Feb-20-20 10:25AM  Meridian Bioscience, Inc. (NASDAQ:VIVO) Earns Among The Best Returns In Its Industry Simply Wall St.
Feb-19-20 01:16PM  One of Cincinnatis largest public companies to acquire rival for $49M American City Business Journals
09:15AM  Meridian Bioscience Signs Definitive Agreement to Acquire Exalenz Bioscience; Adds State-Of-The-Art Urea Breath Test Diagnostics Platform GlobeNewswire
Feb-11-20 08:01AM  Edited Transcript of VIVO earnings conference call or presentation 7-Feb-20 3:00pm GMT Thomson Reuters StreetEvents
Feb-07-20 08:45AM  Meridian Bioscience (VIVO) Beats Q1 Earnings Estimates Zacks -7.03%
07:30AM  Meridian Bioscience Reports First Quarter Fiscal 2020 Operating Results and Reaffirms 2020 Guidance GlobeNewswire
Jan-31-20 12:30PM  Analysts Estimate Meridian Bioscience (VIVO) to Report a Decline in Earnings: What to Look Out for Zacks
Jan-28-20 02:23PM  Coronavirus update: Vaccine stocks retreat and airport screening expands to 20 U.S. airports MarketWatch -10.52%
Jan-27-20 01:19PM  Stock soars for Cincinnati firm that could help combat coronavirus American City Business Journals +20.67%
09:17AM  Meridian Bioscience Lyo-Ready 1-Step RT-qPCR Mix is Used in the Development of Molecular Diagnostics for New Coronavirus Outbreak GlobeNewswire
Jan-23-20 08:00AM  Meridian Launched a New High-Fidelity Polymerase to Offer Robust Amplification for NGS and PCR Applications GlobeNewswire
Jan-21-20 10:11AM  Do You Like Meridian Bioscience, Inc. (NASDAQ:VIVO) At This P/E Ratio? Simply Wall St.
Jan-15-20 04:30PM  Meridian Bioscience to Hold First Quarter 2020 Financial Results Conference Call on February 7, 2020 GlobeNewswire
Dec-30-19 12:48PM  A Duo of Underperforming Stocks to Ease GuruFocus.com
Dec-20-19 02:40PM  Is There An Opportunity With Meridian Bioscience, Inc.'s (NASDAQ:VIVO) 22% Undervaluation? Simply Wall St.
Dec-11-19 09:49AM  Meridian Bioscience, Inc. (VIVO): Are Hedge Funds Right About This Stock? Insider Monkey
Nov-15-19 02:39PM  Multimillion-dollar settlement proposed in lawsuit over stock price at one of regions largest public companies American City Business Journals
Nov-14-19 01:08PM  Edited Transcript of VIVO earnings conference call or presentation 7-Nov-19 3:00pm GMT Thomson Reuters StreetEvents
Nov-07-19 09:15AM  Meridian Bioscience (VIVO) Q4 Earnings and Revenues Surpass Estimates Zacks -16.24%
07:30AM  Meridian Bioscience Reports Fourth Quarter and Full-Year Fiscal 2019 Operating Results and Provides Fiscal 2020 Guidance GlobeNewswire
Nov-06-19 07:30AM  Meridian submits Curian analyzer and the Curian HpSA assay to the FDA GlobeNewswire
Oct-31-19 03:50PM  Is Meridian Bioscience (NASDAQ:VIVO) A Risky Investment? Simply Wall St.
10:34AM  Analysts Estimate Meridian Bioscience (VIVO) to Report a Decline in Earnings: What to Look Out for Zacks
Oct-30-19 05:21PM  Is Meridian Bioscience, Inc. (VIVO) Going to Burn These Hedge Funds? Insider Monkey
Oct-16-19 11:00AM  Meridian Bioscience to Hold Fourth Quarter and Full Year 2019 Financial Results Conference Call on November 7, 2019 GlobeNewswire
Oct-04-19 01:13PM  How Many Meridian Bioscience, Inc. (NASDAQ:VIVO) Shares Have Insiders Sold, In The Last Year? Simply Wall St.
Aug-28-19 07:07AM  Boasting A 14% Return On Equity, Is Meridian Bioscience, Inc. (NASDAQ:VIVO) A Top Quality Stock? Simply Wall St.
Aug-23-19 09:30AM  Should Value Investors Pick Meridian Bioscience (VIVO) Now? Zacks
Aug-10-19 08:34AM  Edited Transcript of VIVO earnings conference call or presentation 30-Jul-19 2:00pm GMT Thomson Reuters StreetEvents
Jul-30-19 02:23PM  Meridian Bioscience Inc (VIVO) Q3 2019 Earnings Call Transcript Motley Fool
08:55AM  Meridian Bioscience (VIVO) Beats Q3 Earnings Estimates Zacks
07:30AM  Meridian Bioscience Reports Third Quarter 2019 Operating Results GlobeNewswire
Jul-23-19 10:32AM  Analysts Estimate Meridian Bioscience (VIVO) to Report a Decline in Earnings: What to Look Out for Zacks
Jul-10-19 04:30PM  Meridian Bioscience to Hold Third Quarter 2019 Financial Results Conference Call on July 30, 2019 GlobeNewswire
Jul-02-19 07:25AM  InMed Pharmaceuticals Appoints Catherine Sazdanoff to Board of Directors CNW Group
Jun-26-19 09:30PM  Heres What Hedge Funds Think About Meridian Bioscience, Inc. (VIVO) Insider Monkey
Jun-04-19 10:34AM  One of Cincinnatis largest public companys closes on $50M acquisition American City Business Journals
Jun-03-19 04:28PM  Meridian Bioscience Announces Closing of Transaction to Acquire Business of GenePOC GlobeNewswire
May-20-19 01:42PM  Meridian Bioscience, Inc. (NASDAQ:VIVO) Earns Among The Best Returns In Its Industry Simply Wall St.
May-09-19 08:45PM  Heres What Hedge Funds Think About Meridian Bioscience, Inc. (VIVO) Insider Monkey
May-03-19 02:21AM  Edited Transcript of VIVO earnings conference call or presentation 30-Apr-19 2:00pm GMT Thomson Reuters StreetEvents
Apr-30-19 11:50AM  Cincinnati public company could pay $120M for Canadian firm American City Business Journals -14.42%
10:38AM  Meridian Bioscience Reports Second Quarter 2019 Operating Results, Suspends Quarterly Cash Dividend, and Provides Fiscal 2019 Guidance for Pending Acquisition Business Wire
10:15AM  Meridian Bioscience (VIVO) Q2 Earnings and Revenues Top Estimates Zacks
10:10AM  Meridian Bioscience Announces Agreement to Acquire Business of GenePOC; Adds State-of-the-Art Molecular Diagnostics Platform Business Wire
09:42AM  Meridian Bioscience Reports Second Quarter 2019 Operating Results, Suspends Quarterly Cash Dividend, and Provides Fiscal 2019 Guidance for Pending Acquisition GlobeNewswire
09:41AM  Meridian Bioscience Announces Agreement to Acquire Business of GenePOC; Adds State-of-the-Art Molecular Diagnostics Platform GlobeNewswire
09:08AM  Meridian Bioscience: Fiscal 2Q Earnings Snapshot Associated Press
Apr-23-19 10:32AM  Analysts Estimate Meridian Bioscience (VIVO) to Report a Decline in Earnings: What to Look Out for Zacks
Apr-19-19 10:43AM  A Look At The Intrinsic Value Of Meridian Bioscience, Inc. (NASDAQ:VIVO) Simply Wall St.
Apr-18-19 08:48AM  Meridian Launches a New Inhibitor Tolerant qPCR Reagent to Significantly Simplify Molecular Diagnostic Workflows From Crude Samples GlobeNewswire
Apr-10-19 04:55PM  Meridian Bioscience to Hold Second Quarter 2019 Financial Results Conference Call on April 30, 2019 GlobeNewswire
Apr-02-19 06:59AM  Meridian Bioscience Announces Preliminary Second Quarter 2019 Revenue Results; Updates Fiscal 2019 Guidance GlobeNewswire -19.32%
Mar-27-19 12:03PM  Why Meridian Bioscience, Inc.s (NASDAQ:VIVO) Cash Is A Factor You Need To Consider Simply Wall St.
Mar-15-19 10:03AM  Here's Why You Should Buy Masimo (MASI) Stock Right Now Zacks
08:31AM  BD's Venovo Gets FDA Nod, Interventional Arm to Get a Boost Zacks
Mar-14-19 08:38AM  Here's Why You Should Invest in Stryker (SYK) Stock Right Now Zacks
Mar-05-19 08:26AM  Did Meridian Bioscience, Inc. (NASDAQ:VIVO) Insiders Sell Shares? Simply Wall St.
Feb-07-19 07:30AM  Meridian Launches New Range of Lyo-Ready PCR Mixes GlobeNewswire
Feb-04-19 08:20AM  Market Trends Toward New Normal in Welltower, Ferrari N.V, Caesars Entertainment, Cohu, Mountain Province Diamonds, and Meridian Bioscience Emerging Consolidated Expectations, Analyst Ratings GlobeNewswire
Feb-01-19 06:44PM  Edited Transcript of VIVO earnings conference call or presentation 24-Jan-19 2:00pm GMT Thomson Reuters StreetEvents
Jan-29-19 04:10PM  Medical Products Industry Outlook: Plenty of Upside Left Zacks
Jan-25-19 09:38PM  Meridian Bioscience (VIVO) Q1 2019 Earnings Conference Call Transcript Motley Fool
Jan-24-19 08:45AM  Meridian Bioscience (VIVO) Tops Q1 Earnings Estimates Zacks
07:41AM  Meridian Bioscience: Fiscal 1Q Earnings Snapshot Associated Press
07:30AM  Meridian Bioscience Reports First Quarter 2019 Operating Results, Declares Regular First Quarter Cash Dividend, and Provides Updated Fiscal 2019 Guidance GlobeNewswire
Jan-23-19 10:14AM  A Spotlight On Meridian Bioscience, Inc.s (NASDAQ:VIVO) Fundamentals Simply Wall St.
Jan-22-19 08:40AM  Ericsson (ERIC) to Report Q4 Earnings: What's in the Cards? Zacks
Jan-08-19 08:15AM  The Daily Biotech Pulse: Amgen Slashes Cholesterol Drug Device Prices By 60%, Takeda Completes Shire Purchase Benzinga -6.34%
Jan-07-19 05:15PM  Meridian Bioscience Announces Preliminary First Quarter 2019 Revenue; First Quarter 2019 Financial Results Conference Call to be Held on January 24, 2019 GlobeNewswire
Dec-06-18 07:30AM  Meridian Gets FDA Clearance for New Neonatal Saliva CMV Test GlobeNewswire
Dec-03-18 08:15AM  Is Meridian Bioscience Inc (NASDAQ:VIVO) A High Quality Stock To Own? Simply Wall St.
Nov-30-18 04:37PM  FDA approves Meridian Bioscience's test for herpes in newborns Reuters
04:08PM  FDA approves Meridian Bioscience's diagnostic for herpes in newborns Reuters
Nov-29-18 09:48AM  Meridian Bioscience Inc (VIVO) Files 10-K for the Fiscal Year Ended on September 30, 2018 GuruFocus.com
07:35AM  Recent Analysis Shows HudBay Minerals, Meridian Bioscience, ArQule, Mesoblast, Concho Resources, and Liberty Global Market Influences Renewed Outlook, Key Drivers of Growth GlobeNewswire
Nov-14-18 05:47PM  Edited Transcript of VIVO earnings conference call or presentation 8-Nov-18 2:00pm GMT Thomson Reuters StreetEvents
Nov-13-18 07:34AM  Meridian Bioscience Inc (NASDAQ:VIVO) Will Pay US$0.13 In Dividends Simply Wall St.
Nov-12-18 11:35AM  What Are Analysts Saying About Meridian Bioscience Incs (NASDAQ:VIVO) Earnings Outlook? Simply Wall St.
Nov-08-18 09:40AM  Meridian Bioscience (VIVO) Q4 Earnings and Revenues Beat Estimates Zacks +15.61%
08:43AM  Meridian Bioscience: Fiscal 4Q Earnings Snapshot Associated Press
07:30AM  Meridian Bioscience Reports Fourth Quarter and Full-Year Operating Results, Sets Fiscal 2019 Cash Dividend Rate, and Provides Fiscal 2019 Guidance GlobeNewswire
Oct-22-18 12:08PM  What Does Meridian Bioscience Incs (NASDAQ:VIVO) PE Ratio Tell You? Simply Wall St.
Oct-19-18 08:40AM  New Research Coverage Highlights TIER REIT, Meridian Bioscience, ArQule, Greenlight Capital Re, ADT, and Turquoise Hill Resources Consolidated Revenues, Company Growth, and Expectations for 2018 GlobeNewswire
Oct-17-18 05:48PM  Meridian Bioscience to Hold Fourth Quarter and Full Year 2018 Financial Results Conference Call on November 8, 2018 GlobeNewswire
Oct-09-18 04:05PM  DiaSorin and Meridian Enter Into a Strategic Collaboration to Sell Helicobacter Pylori Stool Antigen Test in the United States and in the United Kingdom GlobeNewswire
Sep-26-18 09:02AM  Meridian Bioscience Inc (NASDAQ:VIVO): The Yield That Matters The Most Simply Wall St.
Sep-24-18 04:00PM  Meridian Bioscience Announces Retirement of John A. Kraeutler, Executive Chairman of the Board; Appoints David C. Phillips as Chairman of the Board; and Elects Felicia Williams to the Board of Directors GlobeNewswire
Sep-02-18 09:30AM  Should Meridian Bioscience Inc (NASDAQ:VIVO) Be Part Of Your Dividend Portfolio? Simply Wall St.
Aug-16-18 01:27PM  A Look At The Fair Value Of Meridian Bioscience Inc (NASDAQ:VIVO) Simply Wall St.
Jul-31-18 08:50AM  Meridian Bioscience (VIVO) Q3 Earnings Beat Estimates Zacks
07:42AM  Meridian Bioscience: Fiscal 3Q Earnings Snapshot Associated Press
07:30AM  Meridian Bioscience Reports Third Quarter 2018 Operating Results, Declares Regular Third Quarter Cash Dividend, and Reaffirms Fiscal 2018 Guidance GlobeNewswire
Jul-24-18 11:00AM  Quartzy joins with Bioline, Biotium, and MP Biomedicals to create the most diverse digital catalog of lab supplies in the nation GlobeNewswire
Jun-28-18 11:00AM  Meridian Bioscience, Inc. Expects to Report Third Quarter Fiscal Year 2018 Operating Results on Tuesday, July 31, 2018 GlobeNewswire
Jun-21-18 02:03PM  With A -41.16% Earnings Drop, Is Meridian Bioscience Incs (NASDAQ:VIVO) A Concern? Simply Wall St.
May-30-18 02:12PM  Meridian's new CEO is reshaping culture to lay groundwork for growth American City Business Journals
10:54AM  Meridian Introduces Critical Raw Materials for Nipah Virus Diagnosis, a Key Emerging Disease on the WHOs Priority List GlobeNewswire
May-29-18 08:15AM  Research Report Identifies AngioDynamics, Kaiser Aluminum, Mammoth Energy Services, Meridian Bioscience, Merrimack Pharmaceuticals, and Energizer with Renewed Outlook Fundamental Analysis, Calculating Forward Movement GlobeNewswire
Apr-30-18 02:58PM  Is Buying Meridian Bioscience Inc (NASDAQ:VIVO) For Its Upcoming $0.13 Dividend A Good Choice? Simply Wall St.
Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for various gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms and technologies, including real-time PCR amplification under the Revogene brand; isothermal DNA amplification under the Alethia brand; rapid fluorescence-based immunoassay platform under the Curian brand; rapid single-use immunoassays under the ImmunoCard and ImmunoCard STAT! brand names; enzyme-linked immunoassays under the PREMIER brand; and anodic stripping voltammetry, an electrical chemical sensor platform for quantitative determination under the LeadCare and PediaStat brands. This segment's products are primarily used in the detection of infectious diseases caused by various bacteria, viruses, parasites, and pathogens. Its products consists of gastrointestinal assays, including tests for C. difficile, Enterohemorrhagic E. coli, Campylobacter jejuni, H. pylori, Cryptosporidium, giardia lamblia, and calprotectin; respiratory illness assays, such as tests for Group A Streptococcus, Influenza, M. pneumoniae, Bordetella pertussis, and respiratory syncytial virus; blood chemistry assays; and tests for Group B Streptococcus, Chlamydia trachomatis, Neisseria gonorrhea, Herpes Simplex Virus Type 1 and Type 2, and Malaria. This segment sells its products through direct sales force and independent distributors to acute care hospitals, reference laboratories, outpatient clinics, and physician office laboratories. The Life Science segment offers bulk antigens, antibodies, PCR/qPCR reagents, nucleotides, and bioresearch reagents used by researchers, agri-bio companies, and IVD manufacturing companies. Meridian Bioscience, Inc. was incorporated in 1976 and is headquartered in Cincinnati, Ohio.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
PHILLIPS DAVIDDirectorNov 12Buy8.0610,00080,62648,616Nov 13 10:49 AM
Kenny John P.Chief Executive OfficerNov 08Buy7.7320,000154,588198,324Nov 12 08:08 AM
Rice John McCune Jr.DirectorMay 22Buy11.262,00022,5165,981May 23 12:59 PM
Anderson James M.DirectorMay 16Buy11.375,00056,85511,981May 20 02:05 PM
PHILLIPS DAVIDDirectorMay 13Buy11.405,00057,01538,371May 13 03:54 PM
Kenny John P.Chief Executive OfficerMay 08Buy11.4920,000229,74483,000May 09 12:40 PM
open in yahoo | open in reuters | open in google